Citigroup Inc Spdr Ser Tr Spdr S&P Pharmaceu Transaction History

Citigroup Inc

$153 Billion
Q2 2024

A detailed history of Citigroup Inc transactions in Spdr Ser Tr Spdr S&P Pharmaceu stock. As of the latest transaction made, Citigroup Inc holds 1 shares of XPH stock, worth $46. This represents 0.0% of its overall portfolio holdings.

Number of Shares

Previous 1 -0.0%

Holding current value

$46

Previous $0 NaN%

% of portfolio

0.0%

Previous 0.0%

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	SELL	$41.38 - $45.49 $16,552 - $18,196	-400 Reduced 99.75%	1 $0
Q2 2023 Aug 10, 2023	SELL	$39.1 - $42.57 $3,870 - $4,214	-99 Reduced 19.8%	401 $16,000
Q1 2023 May 11, 2023	BUY	$39.61 - $44.25 $3,961 - $4,425	100 Added 25.0%	500 $20,000
Q3 2022 Nov 10, 2022	SELL	$39.59 - $44.52 $98,816 - $111,121	-2,496 Reduced 86.19%	400 $16,000
Q2 2022 Aug 10, 2022	BUY	$38.15 - $46.44 $51,121 - $62,229	1,340 Added 86.12%	2,896 $122,000
Q1 2022 May 12, 2022	SELL	$41.55 - $46.61 $4,071 - $4,567	-98 Reduced 5.93%	1,556 $70,000
Q4 2021 Feb 10, 2022	SELL	$43.72 - $52.45 $20,373 - $24,441	-466 Reduced 21.98%	1,654 $76,000
Q3 2021 Nov 10, 2021	BUY	$46.51 - $53.1 $98,601 - $112,572	2,120 New	2,120 $101,000

Others Institutions Holding XPH

# of Institutions

Shares Held

2.61M

Call Options Held

21.1K

Put Options Held

37.9K

View Full List

About SPDR SER TR SPDR S&P PHARMACEU

Ticker XPH
Sector ETFs
Industry ETFs

More about XPH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.

Account